FDA Should Validate Effectiveness Of Risk Management Tools, PhRMA Says

FDA risk management programs should be evaluated by the agency to determine the value of their implementation, the Pharmaceutical Research & Manufacturers of America maintained during a public workshop on risk management April 10

More from Archive

More from Pink Sheet